Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Recurrence
×
Other solid neoplasm
×
Clear all
Filters
3
NCT06051695
2026-02-20
EVEREST-2
A2 Biotherapeutics Inc.
Phase 1/2
Recruiting
474 enrolled